Subscribe

Josh Canavan

Josh Canavan is the head of pharmacy at RazorMetrics.

Articles by Josh Canavan

Scientist analyzing biosimilars for quality and efficacy, drug comparison, pharmaceutical standards | © Photo18@desing - stock.adobe.com (952831370)

From Promise to Proof: The Shakeup in Today’s Biosimilar Market

May 19th 2026

Latest Updated Articles

Trending on Pharmaceutical Commerce

Pharma Pulse: Medicare's GLP-1 Bridge and FDA's PreCheck Program

What's Really Driving the Direct-to-Patient Boom?